|Polycomb protein EZH2 regulates tumor invasion via the transcriptional repression of the metastasis suppressor RKIP in breast and prostate cancer|
G Ren, S Baritaki, H Marathe, J Feng, S Park, S Beach, PS Bazeley, ...
Cancer research 72 (12), 3091-3104, 2012
|Marizomib, a proteasome inhibitor for all seasons: preclinical profile and a framework for clinical trials|
B C Potts, M X Albitar, K C Anderson, S Baritaki, C Berkers, B Bonavida, ...
Current cancer drug targets 11 (3), 254-284, 2011
|Inhibition of epithelial to mesenchymal transition in metastatic prostate cancer cells by the novel proteasome inhibitor, NPI-0052: pivotal roles of Snail repression and RKIP …|
|Chemotherapeutic drugs sensitize cancer cells to TRAIL-mediated apoptosis: up-regulation of DR5 and inhibition of Yin Yang 1|
S Baritaki, S Huerta-Yepez, T Sakai, DA Spandidos, B Bonavida
Molecular cancer therapeutics 6 (4), 1387-1399, 2007
|Novel therapeutic applications of nitric oxide donors in cancer: roles in chemo-and immunosensitization to apoptosis and inhibition of metastases|
B Bonavida, S Baritaki, S Huerta-Yepez, MI Vega, D Chatterjee, K Yeung
Nitric oxide 19 (2), 152-157, 2008
|The role of B-RAF mutations in melanoma and the induction of EMT via dysregulation of the NF-κB/Snail/RKIP/PTEN circuit|
K Lin, S Baritaki, L Militello, G Malaponte, Y Bevelacqua, B Bonavida
Genes & cancer 1 (5), 409-420, 2010
|Regulation of tumor cell sensitivity to TRAIL-induced apoptosis by the metastatic suppressor Raf kinase inhibitor protein via Yin Yang 1 inhibition and death receptor 5 up …|
S Baritaki, A Katsman, D Chatterjee, KC Yeung, DA Spandidos, ...
The Journal of Immunology 179 (8), 5441-5453, 2007
|Dual role of NO donors in the reversal of tumor cell resistance and EMT: Downregulation of the NF-κB/Snail/YY1/RKIP circuitry|
B Bonavida, S Baritaki
Nitric Oxide 24 (1), 1-7, 2011
|VEGF, FGF2, TGFB1 and TGFBR1 mRNA expression levels correlate with the malignant transformation of the uterine cervix|
G Soufla, S Sifakis, S Baritaki, A Zafiropoulos, E Koumantakis, ...
Cancer letters 221 (1), 105-118, 2005
|Pivotal roles of snail inhibition and RKIP induction by the proteasome inhibitor NPI-0052 in tumor cell chemoimmunosensitization|
S Baritaki, K Yeung, M Palladino, J Berenson, B Bonavida
Cancer research 69 (21), 8376-8385, 2009
|Nitric oxide sensitizes tumor cells to TRAIL-induced apoptosis via inhibition of the DR5 transcription repressor Yin Yang 1|
S Huerta-Yepez, M Vega, SE Escoto-Chavez, B Murdock, T Sakai, ...
Nitric Oxide 20 (1), 39-52, 2009
|Overexpression of VEGF and TGF-β1 mRNA in Pap smears correlates with progression of cervical intraepithelial neoplasia to cancer: implication of YY1 in cervical tumorigenesis …|
S Baritaki, S Sifakis, S Huerta-Yepez, IK Neonakis, G Soufla, B Bonavida, ...
International journal of oncology 31 (1), 69-79, 2007
|Effects of polymorphisms in chemokine ligands and receptors on susceptibility to coronary artery disease|
S Apostolakis, S Baritaki, GE Kochiadakis, NE Igoumenidis, ...
Thrombosis research 119 (1), 63-71, 2007
|Mechanisms of nitric oxide-mediated inhibition of EMT in cancer: inhibition of the metastasis-inducer Snail and induction of the metastasis-suppressor RKIP|
S Baritaki, S Huerta-Yepez, A Sahakyan, I Karagiannides, K Bakirtzi, ...
Cell cycle 9 (24), 4931-4940, 2010
|A novel anticancer effect of butein: inhibition of invasion through the ERK1/2 and NF-κB signaling pathways in bladder cancer cells|
LR Zhang, W Chen, X Li
FEBS letters 582 (13), 1821-1828, 2008
|The novel role of Yin Yang 1 in the regulation of epithelial to mesenchymal transition in cancer via the dysregulated NF-κB/Snail/YY1/RKIP/PTEN Circuitry|
B Bonavida, S Baritaki
Critical Reviews™ in Oncogenesis 16 (3-4), 2011
|Inhibition of Yin Yang 1-dependent repressor activity of DR5 transcription and expression by the novel proteasome inhibitor NPI-0052 contributes to its TRAIL-enhanced apoptosis …|
S Baritaki, E Suzuki, K Umezawa, DA Spandidos, J Berenson, TR Daniels, ...
The Journal of Immunology 180 (9), 6199-6210, 2008
|TRAF6 activation in multiple myeloma: a potential therapeutic target|
H Liu, S Tamashiro, S Baritaki, M Penichet, Y Yu, H Chen, J Berenson, ...
Clinical Lymphoma Myeloma and Leukemia 12 (3), 155-163, 2012
|Genomic instability, mutations and expression analysis of the tumour suppressor genes p14(ARF), p15(INK4b), p16(INK4a) and p53 in actinic keratosis.|
AS P Kanellou, A Zaravinos, M Zioga
Cancer letters, 2008
|Reversal of tumor resistance to apoptotic stimuli by alteration of membrane fluidity: therapeutic implications|
S Baritaki, S Apostolakis, P Kanellou, MT Dimanche‐Boitrel, ...
Advances in cancer research 98, 149-190, 2007